Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians. (2016)
Attributed to:
International Severe Acute Respiratory and Emerging Infections Consortium
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s12871-016-0198-x
PubMed Identifier: 27405596
Publication URI: http://europepmc.org/abstract/MED/27405596
Type: Journal Article/Review
Volume: 16
Parent Publication: BMC anesthesiology
Issue: 1
ISSN: 1471-2253